article thumbnail

Building agile partner relationships at a vaccine-focused biotech

pharmaphorum

In this episode of the pharmaphorum podcast series, Dr Paul Tunnah chats with Jeff Baxter, CEO of VBI Vaccines and Lee Taurman, executive vice president full service commercial at Syneos Health. Jeff Baxter – President and CEO, VBI Vaccines. Whitman School of Management at Syracuse University.

article thumbnail

Drug Channels News Roundup, December 2020: 340B Pharmacy Profits, Pre-Amazon PillPack, Physicians vs. Accumulators, Maine’s Importation Fail, and Vaccine Humor

Drug Channels

Read more » Copyright © 2006-2020 Pembroke Consulting, Inc. P.S. Join the nearly 10,800 followers of my curated links published on @DrugChannels on Twitter. You can also join my nearly 14,000 followers on LinkedIn. It's time to get ready for 2021! Start by joining me next week for my Drug Channels Outlook 2021. to 1:15 p.m.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

HIV vaccines suffer setbacks but new approaches could turn the tide

Pharmaceutical Technology

Only a few weeks into the new year, the prospect of getting a successful advanced HIV vaccine shrank after the discontinuation of yet another late-stage trial. On January 18, Janssen, a Johnson & Johnson (J&J) subsidiary, stated that its vaccine was not effective in preventing HIV infections.

Vaccines 117
article thumbnail

Opinion: A bipartisan opportunity to strengthen America’s pandemic security

STAT

In 2006, when many Americans had barely heard the word “coronavirus,” Congress passed the Pandemic and All Hazards Preparedness Act (PAHPA), a landmark, bipartisan legislative framework that has successfully steered our nation’s biosecurity policy ever since.

Vaccines 177
article thumbnail

3 steps for comprehensive patient collaboration

pharmaphorum

In 2006 he joined the Janssen teams working in Infectious Diseases where he helped to maintain and enhance the company’s relationships with the HIV Patient Community. Later, he built the external relationships in the field of Hepatitis C, before becoming the Global Therapeutic Area Communications Leader Infectious Diseases and Vaccines.

article thumbnail

Millions of peoples’ access to affordable medicines at risk if India-EFTA trade deal finalised as is: MSF

Express Pharma

This is because MSF relies on quality-assured vaccines and medicines made in India to treat the people under their care, with its spending on generic medicines procured from India estimated at 95 per cent for HIV, 90 per cent for hepatitis C antivirals, 36 per cent on TB treatments, and 30 per cent on vaccines.

article thumbnail

Biosimilars: a rapidly maturing market

pharmaphorum

The global health crisis caused spending on healthcare to increase , due to the funding provided to the development and purchases of vaccines and treatments, as well as support provided for the associated infrastructure. The short story so far.